Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Reagent kit for detecting heart brain disease genetic susceptibility

A kit, susceptibility technology, applied in the fields of molecular biology and medicine, can solve problems such as discomfort, decreased ability to metabolize acetaldehyde, alcoholism, etc.

Inactive Publication Date: 2009-01-28
XINBAXIANG SHANGHAI MOLECULAR MEDICAL TECH SHANGHAI
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In contrast, the risk of Alzheimer's disease among people who tested negative for the e4 allele of the APOE gene was less than 10%.
The rs671 polymorphic change (G / A) defect of the ALDH2 gene leads to a decrease in the body's ability to metabolize acetaldehyde, causing discomfort in drinking, flushing syndrome, etc., and easily leading to alcoholism

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0014] Example 1. Use of detection kits

[0015] Step 1: Extraction of DNA template

[0016] Genomic DNA of oral epithelial cells was extracted by silica gel adsorption.

[0017] Step 2: Real-time quantitative PCR reaction

[0018] Using the detection kit, an independent fluorescent quantitative PCR reaction was carried out for each SNP site. The total volume of each reaction was 10 μl, including 2 μl of DNA template with a concentration of 20 ng / μl, 1 μl of 10X fluorescent quantitative PCR reaction buffer, 0.1μl 25mM dNTP mixture, 0.6μl 25mM MgCl 2 solution, 0.025 μl (5 units / μl) Taq DNA polymerase, 0.225 μl each of 20 μM primers, 0.25 μl each of 10 μM fluorescent probes, and 5.325 μl of deionized water.

[0019] The reaction was carried out on an ABI9700 type PCR amplification instrument, and the reaction conditions were 50° C. for 2 minutes, 95° C. for 10 minutes, and 60 cycles of 95° C. for 30 seconds and 60° C. for 1 minute. After the reaction, the fluorescence of the...

Embodiment 2

[0022] Example 2. Services for detection of genetic susceptibility to heart and brain diseases

[0023] Step 1: DNA Extraction

[0024] The physicians in the laboratory department of the hospital instructed the subjects to use oral swabs to sample oral epithelial cells, and the silica gel adsorption method was used to extract DNA from oral epithelial cells.

[0025] Step 2: Genotyping Assays

[0026] Use the kit provided by the present invention to detect ABCA1, ACE, ADIPOQ, AGT, APOB, APOE, AT1R, CYP11B2, ENOS, LEP, LPL, MTHFR, PON1, PPARG, SOD3, UCP2 and VDR genes on the genomic DNA of the subject The 18 SNP sites were detected by fluorescent quantitative PCR to determine the genotypes of these SNP sites.

[0027] Step 3: Analysis of genetic susceptibility to heart and brain diseases

[0028] Through the analysis of the SNPs genotypes of the subjects, an analysis report of genetic susceptibility to heart and brain diseases is issued, and the doctor explains and interprets...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a kit used for detecting the genetic susceptibility of cardio-cerebral diseases. The kit comprises a specific primer pair which detects genotypes of eighteen sites of single nucleotide polymorphism (SNP) in ABCA1, ACE, ADIPOQ, AGT, APOB, APOE, AT1R, CYP11B2, ENOS, LEP, LPL, MTHFR, PON1, PPARG, SOD3, UCP2 and VDR simultaneously and specified fluorescent probe pairs, conventional components used in fluorescence quantitative PCR detecting, and the like. The kit of the invention evaluates genetic susceptibility of cardio-cerebral diseases by detecting genotypes of eighteen sites of single nucleotide polymorphism which is closely related to genetic susceptibility of cardio-cerebral diseases.

Description

technical field [0001] The present invention relates to the fields of molecular biology and medicine, more specifically, the present invention relates to a kit for detecting genetic susceptibility to heart and brain diseases, which can be used to assess individual heart and brain diseases by detecting and analyzing genes related to the genetic risk of heart and brain diseases genetic predisposition. Background technique [0002] Genetic detection and analysis technology has rapidly become an important tool for predicting human disease and health. Gene technology can correlate human health status with physiological diseases, genetic mutation factors, disease tendency and status, etc. Genetic factor mutations caused by base insertions, deletions, and mismatches in DNA sequences, as well as up-and-down regulation of individual DNA expressions, are all biological information related to health status and disease mechanisms. [0003] For example, "senile dementia" is a persisten...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N21/00G01N33/50C12Q1/68
Inventor 邹祖烨冯哲民
Owner XINBAXIANG SHANGHAI MOLECULAR MEDICAL TECH SHANGHAI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products